Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

820.41
Delayed Data
As of Mar 27
 +0.41 / +0.05%
Today’s Change
538.01
Today|||52-Week Range
832.48
+13.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Stahl Neil
Executive Vice President-Research & Development
Sale8/04/202271,218$613.00$43.7M+33.41%
Van Plew Daniel P
Sale11/22/202238,028$741.81$28.2M+9.50%
Van Plew Daniel P
Sale9/09/202235,304$730.96$25.8M+13.27%
Stahl Neil
Executive Vice President-Research & Development
Buy8/04/202295,000$270.43$25.7M+33.41%
Van Plew Daniel P
Buy9/09/202240,000$555.67$22.2M+13.27%
Vagelos P Roy
Director
Sale2/22/202329,005$750.16$21.8M+9.67%
Van Plew Daniel P
Sale11/04/202226,114$725.84$19.0M+10.83%
Van Plew Daniel P
Buy11/22/202250,000$378.98$18.9M+9.50%
Larosa Joseph J
Sale9/09/202220,730$730.96$15.2M+13.27%
Van Plew Daniel P
Buy11/04/202234,000$381.92$13.0M+10.83%
Page of 51